Silvia P. Corona

823-865 Centre Rd
Bentleigh East, VIC 3165, Australia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 43 publications

Diagnostic accuracy of modern imaging following neoadjuvant therapy for breast cancer: a comparative analysis of ultrasound versus [18F] FDG PET/MRI in breast response assessment.

Diagnostic accuracy of modern imaging following neoadjuvant therapy for breast cancer: a comparative analysis of ultrasound versus [18F] FDG PET/MRI in breast response assessment.

Journal: Frontiers in oncology

Published: April 01, 2026

[18F]FDG PET/MRI for axillary staging in node positive breast cancer patients receiving primary systemic therapy. A prospective single arm trial.

[18F]FDG PET/MRI for axillary staging in node positive breast cancer patients receiving primary systemic therapy. A prospective single arm trial.

Journal: Breast (Edinburgh, Scotland)

Published: February 11, 2026

Pre-Pectoral Breast Reconstruction after Mastectomy: Current Evidence, Knowledge Gaps, and Rationale for the I-PREPARE EUBREAST-11R Trial.

Pre-Pectoral Breast Reconstruction after Mastectomy: Current Evidence, Knowledge Gaps, and Rationale for the I-PREPARE EUBREAST-11R Trial.

Journal: Breast care (Basel, Switzerland)

Published: December 17, 2025

[18F]FDG PET/MRI vs sentinel node biopsy for axillary staging of early breast cancer patients. A prospective single-arm trial.

[18F]FDG PET/MRI vs sentinel node biopsy for axillary staging of early breast cancer patients. A prospective single-arm trial.

Journal: European journal of cancer (Oxford, England : 1990)

Published: April 07, 2025

Addendum: Impact of BMI on the outcome of metastatic breast cancer patients treated with everolimus: a retrospective exploratory analysis of the BALLET study.

Addendum: Impact of BMI on the outcome of metastatic breast cancer patients treated with everolimus: a retrospective exploratory analysis of the BALLET study.

Journal: Oncotarget

Published: December 06, 2022

Dual drug targeting to kill colon cancers.

Dual drug targeting to kill colon cancers.

Journal: Cancer medicine

Published: September 20, 2021

Erratum to 'Poly (ADP-ribose) polymerase inhibitors in solid tumours: Systematic review and meta-analysis' [Eur J Cancer 149 (2021) 134-152].

Erratum to 'Poly (ADP-ribose) polymerase inhibitors in solid tumours: Systematic review and meta-analysis' [Eur J Cancer 149 (2021) 134-152].

Journal: European journal of cancer (Oxford, England : 1990)

Published: June 28, 2021

Clinical, Radiometabolic and Immunologic Effects of Olaparib in Locally Advanced Triple Negative Breast Cancer: The OLTRE Window of Opportunity Trial.

Clinical, Radiometabolic and Immunologic Effects of Olaparib in Locally Advanced Triple Negative Breast Cancer: The OLTRE Window of Opportunity Trial.

Journal: Frontiers in oncology

Published: March 27, 2021

Poly (ADP-ribose) polymerase inhibitors in solid tumours: Systematic review and meta-analysis.

Poly (ADP-ribose) polymerase inhibitors in solid tumours: Systematic review and meta-analysis.

Journal: European journal of cancer (Oxford, England : 1990)

Published: December 11, 2020

Tumor Type Agnostic Therapy Carrying BRAF Mutation: Case Reports and Review of Literature.

Tumor Type Agnostic Therapy Carrying BRAF Mutation: Case Reports and Review of Literature.

Journal: Pharmaceuticals (Basel, Switzerland)

Published: December 11, 2020

Early Changes of the Standardized Uptake Values (SUVmax) Predict the Efficacy of Everolimus-Exemestane in Patients with Hormone Receptor-Positive Metastatic Breast Cancer.

Early Changes of the Standardized Uptake Values (SUVmax) Predict the Efficacy of Everolimus-Exemestane in Patients with Hormone Receptor-Positive Metastatic Breast Cancer.

Journal: Cancers

Published: September 23, 2020

Expression patterns and clinical significance of the potential cancer stem cell markers OCT4 and NANOG in colorectal cancer patients.

Expression patterns and clinical significance of the potential cancer stem cell markers OCT4 and NANOG in colorectal cancer patients.

Journal: Molecular & cellular oncology

Published: September 18, 2020

Showing 1-12 of 43

Last Updated: 09/26/2026